Vertaling van "pfizer research " (Nederlands → Frans) :

TERMINOLOGIE

Mason-Pfizer apenvirus
virus Mason-Pfizer du singe

research | wetenschappelijk onderzoek
recherche | recherche

IN-CONTEXT TRANSLATIONS

Pfizers toonaangevende onderzoeks- en ontwikkelingscentra in Groton maken Connecticut tot de hoofdvestiging van Pfizer Research & Development.
Le centre de recherche et de développement pionnier de Groton fait du Connecticut le cœur de Pfizer Biotherapeutics et Pharmatherapeutics Research & Development.

Pfizer Biotherapeutics en Pfizer Pharmatherapeutics Research & Development telt vijf belangrijke vestigingen, vier in de Verenigde Staten en één in Engeland.
Pfizer Biotherapeutics et Pharmatherapeutics Research & Development possède cinq sites majeurs – quatre aux Etats-Unis et un en Grande-Bretagne.

De activiteiten van Pfizer kunnen ruwweg onderverdeeld worden in 4 entiteiten: Worldwide Research & Development, Pfizer Global Manufacturing, Worldwide Biopharmaceutical Businesses en Pfizer Diversified Businesses.
Les activités de Pfizer sont réparties en 4 entités : Worldwide Research & Development, Pfizer Global Manufacturing, Worldwide Biopharmaceutical Businesses et Pfizer Diversified Businesses .

De Europese hoofdvestiging van Biotherapeutics en Pharmatherapeutics Research & Development in het Engelse Sandwich speelt een belangrijke rol in de ontwikkeling van nieuwe Pfizer-geneesmiddelen.
Le siège européen de Pfizer Biotherapeutics et Pharmatherapeutics Research & Development , situé à Sandwich, en Grande-Bretagne, joue un rôle prépondérant dans le développement de nouveaux médicaments Pfizer.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

Onze Fase I-eenheid van Pfizer, die ook bekend staat als de Pfizer Clinical Research Unit (PCRU) bevindt zich op de twee bovenste verdiepingen van het Erasmus dagziekenhuis.
Dans le monde, Pfizer compte 3 Unités de Phase I, une à Singapour, une aux Etats-Unis à New Haven, et la troisième en Belgique à Anderlecht sur le site de l'hôpital Erasme, sur le campus universitaire du même nom. Notre Unité de Phase I de Pfizer, également appelée Pfizer Clinical Research Unit (PCRU), se trouve aux deux derniers étages de l’hôpital de jour de l’hôpital Erasme.

Pfizer Brussels Clinical Research Unit Route de Lennik 808 - 1070 Anderlecht Tel.: + 32 (0)2 556 70 11
Pfizer Brussels Clinical Research Unit Route de Lennik 808 - 1070 Anderlecht Tél.: + 32 (0)2 556 70 11